Thomas Lienard
Direktor/Vorstandsmitglied bei ANTIGON SA
Aktive Positionen von Thomas Lienard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Antigon SA develops, manufactures, and supplies blood safety transfusion devices. The company is based in Charleroi, Belgium. Antigon was founded in 2016 by Francis Corazza, Hanane El Kenz, and Thierry Baltus. | Direktor/Vorstandsmitglied | 01.07.2020 | - |
Karriereverlauf von Thomas Lienard
Ehemalige bekannte Positionen von Thomas Lienard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOSENIC SA | Direktor/Vorstandsmitglied | 31.10.2016 | 01.01.2020 |
Vorstandsvorsitzender | 31.10.2016 | 01.01.2020 | |
Public Communications Contact | 01.11.2015 | 01.01.2020 | |
Corporate Officer/Principal | 01.11.2015 | 31.10.2016 | |
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Benelux SA is a pharmaceutical company based in Brussels, Belgium. The Belgian company focuses on research and development to discover and offer innovative medicines that improve the quality of life for people worldwide. Lilly has established policies, standards, and protective measures for the entire research and development process to ensure that the patient remains the top priority. The CEO of the company is Frederic Clais. | Vertrieb & Marketing | 01.01.2010 | - |
Prométhéa Asbl | Direktor/Vorstandsmitglied | - | - |
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Vorstandsvorsitzender | - | - |
Ausbildung von Thomas Lienard
Harvard Business School | Masters Business Admin |
Solvay Business School of Economics & Management | Graduate Degree |
Statistik
International
Belgien | 7 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Public Communications Contact | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Benelux SA is a pharmaceutical company based in Brussels, Belgium. The Belgian company focuses on research and development to discover and offer innovative medicines that improve the quality of life for people worldwide. Lilly has established policies, standards, and protective measures for the entire research and development process to ensure that the patient remains the top priority. The CEO of the company is Frederic Clais. | Health Technology |
Bone Therapeutics SA
Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Health Technology |
Prométhéa Asbl | |
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Antigon SA develops, manufactures, and supplies blood safety transfusion devices. The company is based in Charleroi, Belgium. Antigon was founded in 2016 by Francis Corazza, Hanane El Kenz, and Thierry Baltus. | Health Technology |
- Börse
- Insiders
- Thomas Lienard
- Erfahrung